Loren Saulsberry is the Assistant Program Leader of the Cancer Prevention and Control Program within the UChicago Medicine Comprehensive Cancer Center and the Assistant Director of Diversity Studies in the UChicago Center for Personalized Therapeutics. As a health policy and health services researcher, Dr. Saulsberry investigates the experiences of vulnerable populations managing chronic conditions, especially those underrepresented and medically underserved. Her research interests include: (1) health policies and services that impact precision medicine delivered across the care continuum from prevention and early detection to cancer outcomes, (2) the relationships between politics and health communication, (3) the determinants contributing to health disparities affecting diverse populations, especially across race/ethnicity and socioeconomic status.

Harvard University
Boston, MA
Ph.D. - Health Policy
2017

Wellesley College
Wellesley, MA
B.A. - Neuroscience, English
2010

Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions.
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
PMID: 38271180

Medicaid Privatization: Has the Invisible Hand Led Us Astray?
Medicaid Privatization: Has the Invisible Hand Led Us Astray? JCO Oncol Pract. 2024 Feb 16; OP2300820.
PMID: 38364195

The impact of neighborhood disadvantage on colorectal cancer screening among African Americans in Chicago.
The impact of neighborhood disadvantage on colorectal cancer screening among African Americans in Chicago. Prev Med Rep. 2023 Aug; 34:102235.
PMID: 37252073

Social Vulnerability and Risk of Suicide in US Adults, 2016-2020.
Social Vulnerability and Risk of Suicide in US Adults, 2016-2020. JAMA Netw Open. 2023 04 03; 6(4):e239995.
PMID: 37099296

"Everything in One Place": Stakeholder Perceptions of Integrated Medical and Social Care for Diabetes Patients in Western Maryland.
"Everything in One Place": Stakeholder Perceptions of Integrated Medical and Social Care for Diabetes Patients in Western Maryland. J Gen Intern Med. 2023 03; 38(Suppl 1):25-32.
PMID: 36864266

The social vulnerability metric (SVM) as a new tool for public health.
The social vulnerability metric (SVM) as a new tool for public health. Health Serv Res. 2023 08; 58(4):873-881.
PMID: 36401593

Shifting the Paradigm: Reimagining Approaches to Diversifying the Leadership of the Nation's Cancer Centers.
Shifting the Paradigm: Reimagining Approaches to Diversifying the Leadership of the Nation's Cancer Centers. J Natl Cancer Inst. 2022 09 09; 114(9):1209-1211.
PMID: 35897142

Quality of Care for US Adults With Medicaid Insurance and Type 2 Diabetes in Federally Qualified Health Centers Compared With Other Primary Care Settings.
Quality of Care for US Adults With Medicaid Insurance and Type 2 Diabetes in Federally Qualified Health Centers Compared With Other Primary Care Settings. Med Care. 2022 11 01; 60(11):813-820.
PMID: 36040020

Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System.
Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System. J Pers Med. 2022 Jul 15; 12(7).
PMID: 35887642

Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients.
Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021 Dec 10; 11(12).
PMID: 34945816

View All Publications

K Award
Central Society for Clinical and Translational Research (CSCTR)
2022

Human Genetics Scholar
American Society of Human Genetics (ASHG)
2020 - 2022

North Coast Conference on Precision Medicine Travel Award
Cleveland Institute for Computational Biology, Case Western Reserve University
2019